Toshinori Ando

J-GLOBAL         Last updated: Nov 17, 2019 at 04:12
 
Avatar
Name
Toshinori Ando
Affiliation
Hiroshima University

Research Areas

 
 

Academic & Professional Experience

 
Sep 2018
 - 
Mar 2020
Assistant professor (Special appointment), (by cross-appointment), Hiroshima University
 
Sep 2017
 - 
Mar 2020
Postdoctoral Employee, Moores Cancer Center, University of California, San Diego
 
Mar 2015
 - 
Aug 2017
Assistant professor, Department of oral and maxillofacial path-biology, Hiroshima University
 
Apr 2010
 - 
Mar 2011
Resident of dentistry, Dentistry, Hiroshima University Hospital
 

Education

 
Apr 2011
 - 
Mar 2015
Oral and maxillofacial pathobiology, Hiroshima University
 
Apr 2004
 - 
Mar 2010
Faculty of Dentistry, Hiroshima University
 

Awards & Honors

 
Sep 2016
Poster Award (18th International Congress on Oral Pathology and Medicine) , International association of oral and maxillofacial pathologists
 
Dec 2013
Poster Award(5th Hiroshima Conference on Education and Science in Dentistry), Hiroshima University
 
Mar 2013
2013 IADR/Unilever Hatton Divisional Award, International association for dental research
 

Published Papers

 
Wu X, Yeerna H, Goto Y, Ando T, Wu VH, Zhang X, Wang Z, Amornphimoltham P, Murphy AN, Tamayo P, Chen Q, Lippman SM, Gutkind JS
Cancer research   79(17) 4360-4370   Sep 2019   [Refereed]
Shrestha M, Ando T, Chea C, Sakamoto S, Nishisaka T, Ogawa I, Miyauchi M, Takata T
Carcinogenesis      May 2019   [Refereed]
Nakajima K, Kunimatsu R, Ando K, Ando T, Hayashi Y, Kihara T, Hiraki T, Tsuka Y, Abe T, Kaku M, Nikawa H, Takata T, Tanne K, Tanimoto K
Biochemical and biophysical research communications   497(3) 876-882   Mar 2018   [Refereed]
Miyauchi M, Ao M, Furusho H, Chea C, Nagasaki A, Sakamoto S, Ando T, Inubushi T, Kozai K, Takata T
Scientific reports   8(1) 2867   Feb 2018   [Refereed]
Ando T, Charindra D, Shrestha M, Umehara H, Ogawa I, Miyauchi M, Takata T
Oncogene   37(2) 263-270   Jan 2018   [Refereed]

Conference Activities & Talks

 
Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma.
Toshinori Ando
The 28th annual meeting of the Japanese Society of Oral Pathology   24 Aug 2017   
encouragement award
TIMP-1 promotes tumor cell proliferation through YAP activation.
Toshinori Ando
The 106th Annual Meeting of the Japanese Society of Pathology   27 Apr 2017   
Ameloblastin induces tumor suppression and chemosensitivity in osteosarcoma.
Toshinori Ando
18th International Congress on Oral Pathology and Medicine & XXV Conference of Indian Association of Oral and Maxillofacial Pathologists   8 Sep 2016   
Poster award
Ameloblastin induces tumor suppression and chemosensitivity in osteosarcoma doxorubicin in osteosarcoma
Toshinori Ando
The 26th Annual Meeting of the Japanese Society of Oral Pathology   29 Jul 2015   
Ameloblastin enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma
Toshinori Ando
The 104th Annual Meeting of the Japanese Society of Pathology   30 Apr 2015   

Research Grants & Projects

 
Japan Society for the Promotion of Science: Grants-in-aid (B)
Project Year: Apr 2017 - Mar 2018    Investigator(s): Toshinori Ando